Showing 1041-1050 of 9461 results for "".
MYDON by Quantel Derma - Perfect for Spider Veins
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/mydon-by-quantel-derma-perfect-for-spider-veins/19375/The Nd:YAG laser system is the ideal treatment solution for vascular skin changes such as spider veins or varicosis. With proven 1064 nm wavelength and integrated contact cooling before, during and after each laser pulse. The effective Burst Mode lets you treat vessels of up to 5 mm. Various handpiePrurigo Nodularis in Skin of Color: Recognizing Distinct Clinical Presentations
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/prurigo-nodularis-in-skin-of-color-recognizing-distinct-clinical-presentations/57012/Cheri Frey, MD, discusses how prurigo nodularis may present differently in patients with skin of color, highlighting diagnostic challenges, variations in inflammation, and the importance of recognizing disease manifestations across diverse skin tones.TOGETHER-PsO: Dual Therapy for Psoriasis and Obesity
https://practicaldermatology.com/videos/skin-minute/together-pso-dual-therapy-for-psoriasis-and-obesity/57262/Mark G. Lebwohl, MD, provides key takeaways and commentary on the results of the TOGETHER-PsO study, which looked at a combination therapy of ixekizumab (Taltz) and tirzepatide (Zepbound) in patients with both psoriasis and obesity.Finding the Right Medication for the Right Patient with Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37180/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, explains how to select the optimal therapeutic option for each different atopic dermatitis patient.Comparing Sunscreen for Skin of Color: Print-Ready Charts for Download
https://practicaldermatology.com/topics/skin-cancer-photoprotection/comparing-sunscreen-for-skin-of-color-print-ready-charts/56515/Click the image to download the print-ready PDFsAddressing Itch in Prurigo Nodularis Clinical Trials
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37170/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, addresses how future prurigo nodularis trials could better address the heterogeneity in disease burden and patient-reported outcomes.Food Allergies and Atopic Dermatitis in the Pediatric Population
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/food-allergies-and-atopic-dermatitis-in-the-pediatric-population/37175/Elizabeth Lippner, MD, MA, Attending Physician in the Division of Allergy and Immunology and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine, discusses potential links between food allergies and pediatric atopic dermatitis, and how to address them.IL-31’s Role in Prurigo Nodularis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/il-31s-role-in-prurigo-nodularis/48804/Raj Chovatiya, MD, PhD, MSCI, FAAD, explains the role of the IL-31 pathway in neuroinflammatory disease such as prurigo nodularis.Practical Strategies for Improving Patient Adherence with Topical Regimens
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/practical-strategies-for-improving-patient-adherence-with-topical-regimens/39707/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, describes tactics involving topical therapeutics to improve patient adherence with atopic dermatitis.The Battle of Biostimulators: PLLA vs Hyperdilute CaHA
https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/the-battle-of-biostimulators-plla-vs-hyperdilute-caha/39250/Modern Aesthetics executive editor Kay Durairaj, MD, FACS, hosts a workshop describing the differences between two dermal filler options, and how she utilizes both in her practice. YoungMD Connect is an editorially independent platform made possible by industry sponsorships. We would like to thank o